Effectiveness and Safety of Dapagliflozin for Black vs White Patients With Chronic Kidney Disease in North and South America: A Secondary Analysis of a Randomized Clinical Trial

Priya Vart; Niels Jongs; David C. Wheeler; Hiddo J.L. Heerspink; Anna Maria Langkilde; Glenn M. Chertow

doi:10.1001/jamanetworkopen.2023.10877

Effectiveness and Safety of Dapagliflozin for Black vs White Patients With Chronic Kidney Disease in North and South America: A Secondary Analysis of a Randomized Clinical Trial

Priya Vart^*
, Niels Jongs
, David C. Wheeler
, Hiddo J.L. Heerspink
, Anna Maria Langkilde
, Glenn M. Chertow

^*Corresponding author for this work

Research output: Contribution to journal › Letter (Research letter) › Academic › peer-review

7 Citations (Scopus)

97 Downloads (Pure)

Original language	English
Article number	E2310877
Number of pages	4
Journal	Jama network open
Volume	6
Issue number	4
DOIs	https://doi.org/10.1001/jamanetworkopen.2023.10877
Publication status	Published - 27-Apr-2023

Access to Document

10.1001/jamanetworkopen.2023.10877Licence: CC BY-NC-ND

Effectiveness and Safety of Dapagliflozin for Black and White Patients With Chronic Kidney Disease in North and South AmericaFinal publisher's version, 427 KBLicence: CC BY-NC-ND

Handle.net

Persistent link

Cite this

Vart, P., Jongs, N., Wheeler, D. C., Heerspink, H. J. L., Langkilde, A. M., & Chertow, G. M. (2023). Effectiveness and Safety of Dapagliflozin for Black vs White Patients With Chronic Kidney Disease in North and South America: A Secondary Analysis of a Randomized Clinical Trial. Jama network open, 6(4), Article E2310877. https://doi.org/10.1001/jamanetworkopen.2023.10877

@article{795b84d1bb4a4085beb2f81b63d239b6,

title = "Effectiveness and Safety of Dapagliflozin for Black vs White Patients With Chronic Kidney Disease in North and South America: A Secondary Analysis of a Randomized Clinical Trial",

author = "Priya Vart and Niels Jongs and Wheeler, \{David C.\} and Heerspink, \{Hiddo J.L.\} and Langkilde, \{Anna Maria\} and Chertow, \{Glenn M.\}",

note = "Funding Information: Funding/Support: This trial was funded by AstraZeneca. ",

year = "2023",

month = apr,

day = "27",

doi = "10.1001/jamanetworkopen.2023.10877",

language = "English",

volume = "6",

journal = "Jama network open",

issn = "2574-3805",

publisher = "AMER MEDICAL ASSOC",

number = "4",

}

Effectiveness and Safety of Dapagliflozin for Black vs White Patients With Chronic Kidney Disease in North and South America: A Secondary Analysis of a Randomized Clinical Trial. / Vart, Priya ; Jongs, Niels; Wheeler, David C. et al.
In: Jama network open, Vol. 6, No. 4, E2310877, 27.04.2023.

Research output: Contribution to journal › Letter (Research letter) › Academic › peer-review

TY - JOUR

T1 - Effectiveness and Safety of Dapagliflozin for Black vs White Patients With Chronic Kidney Disease in North and South America

T2 - A Secondary Analysis of a Randomized Clinical Trial

AU - Vart, Priya

AU - Jongs, Niels

AU - Wheeler, David C.

AU - Heerspink, Hiddo J.L.

AU - Langkilde, Anna Maria

AU - Chertow, Glenn M.

N1 - Funding Information: Funding/Support: This trial was funded by AstraZeneca.

PY - 2023/4/27

Y1 - 2023/4/27

U2 - 10.1001/jamanetworkopen.2023.10877

DO - 10.1001/jamanetworkopen.2023.10877

M3 - Letter (Research letter)

C2 - 37103935

AN - SCOPUS:85158082163

SN - 2574-3805

VL - 6

JO - Jama network open

JF - Jama network open

IS - 4

M1 - E2310877

ER -